MedPath

广东九明制药有限公司

Ownership
-
Established
2001-10-16
Employees
-
Market Cap
-
Website
http://www.gdjmzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

Mecobalamin Tablets

Product Name
甲钴胺片
Approval Number
国药准字H20254370
Approval Date
May 27, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20253436
Approval Date
Feb 20, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20253434
Approval Date
Feb 20, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20253435
Approval Date
Feb 20, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20249761
Approval Date
Dec 17, 2024
NMPA

Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution

Product Name
氨溴特罗口服溶液
Approval Number
国药准字H20249392
Approval Date
Nov 15, 2024
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20244464
Approval Date
Jul 16, 2024
NMPA

Levocetirizine Dihyrochloride Oral Drops

Product Name
盐酸左西替利嗪口服滴剂
Approval Number
国药准字H20243034
Approval Date
Jan 9, 2024
NMPA

Desloratadine Capsules

Product Name
地氯雷他定胶囊
Approval Number
国药准字H20138004
Approval Date
May 23, 2023
NMPA

Desloratadine Tablets

Product Name
地氯雷他定片
Approval Number
国药准字H20138005
Approval Date
May 23, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.